Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Harm Reduction in Peer-Assisted Telemedicine for Hepatitis C: Secondary Outcomes of a Randomized Controlled Trial

Viruses(2024)10.3390/v16091455Source: DataRank Database

Harm Reduction in Peer-Assisted Telemedicine for Hepatitis C: Secondary Outcomes of a Randomized Controlled Trial is a research paper published in Viruses (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.25)OA: goldTopics (46)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Devin Gregoire,Gillian Leichtling,Megan C. Herink ORCID,Andrew Seaman ORCID,P. Todd Korthuis ORCID

Live enrichment

PubMed:39339931 OpenAlex:https://openalex.org/W4402526285

National Institutes of Health

Grant: UH3DA044831

National Institutes of Health

Grant: UG1DA015815

National Institutes of Health

Grant: KL2TR002370

National Institutes of Health

Grant: K01 DA55130

National Institutes of Health

Grant: 5KL2TR002370-09

Institutional Career Development Core

National Institutes of Health

Grant: 5UH3DA044831-05

Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study

National Institutes of Health

Grant: 3UG1DA015815-21S2

Medication for Opioid Use Disorder, Predictability of Retention vs Attrition

National Institutes of Health

Grant: 1K01DA055130-01A1

Transporting treatment effects from clinical trials to real-world populations with co-occurring opioid and stimulant use disorders

FWCI

0.25

Citation Percentile

0.5%

Citation Trend

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1999-4915/16/9/1455/pdf?version=1726202041

GOLDhttps://doi.org/10.3390/v16091455

publisherhttps://www.mdpi.com/1999-4915/16/9/1455/pdf?version=1726202041

publisherhttps://www.mdpi.com/1999-4915/16/9/1455/pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39339931

Fields of Study

Hepatitis C virus researchHIV, Drug Use, Sexual RiskHIV/AIDS Research and InterventionsMedicine03 medical and health sciences0305 other medical science

MeSH Terms

AdultFemaleHepatitis CHumansMaleMiddle AgedPeer GroupRisk-TakingSubstance Abuse, IntravenousNeedle SharingTelemedicineHarm Reduction

Keywords

Randomized controlled trialHarm reductionTelemedicineReduction (mathematics)HarmMedicineVirologyInternal medicinePsychologyHealth careHuman immunodeficiency virus (HIV)Political scienceSocial psychologyMaleAdultMiddle AgedMicrobiologyHepatitis CQR1-502ArticlePeer GroupRisk-TakingHumansFemaleNeedle SharingSubstance Abuse, Intravenoushepatitis C virus (HCV)people who use drugs (PWUD)